Your session is about to expire
← Back to Search
Dexmedetomidine for Acute Pain from Rib Fractures
Study Summary
This trial is studying whether using dexmedetomidine to manage pain in patients with 3 or more rib fractures is effective and safe.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 4 trial • 798 Patients • NCT02004613Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have more than three broken ribs from a blunt injury.I have severe liver disease.I am under 18 years old.You had a bad reaction to dexmedetomidine in the past.Your heart beats too slowly.I can communicate clearly without any issues.I have been admitted to the Intensive Care Unit.Your blood pressure is too low.I am currently experiencing a worsening of my heart failure symptoms.My consciousness level is somewhat impaired.I am currently taking more than 30mg of opioids daily.
- Group 1: Precedex arm
- Group 2: Control arm
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are any new participants being admitted to this clinical trial at the present time?
"According to the clinicaltrials.gov database, this research project is currently enrolling participants. The investigation was initially submitted on March 14th 2022 and has since been revised as of April 7th 2022."
Has the Food and Drug Administration sanctioned Dexmedetomidine?
"There is significant evidence indicating the safety of Dexmedetomidine, so it garnered a rating of 3 on our scale. This drug has officially been approved for medical use and can be found in Phase 4 clinical trials."
How many participants are being enlisted in this medical trial?
"Affirmative. According to records compiled on clinicaltrials.gov, this medical study is currently seeking participants; it was first posted in March 14th 2022 and the most recent update occurred April 7th 2022. The requirement is for 60 individuals from a single site."
What are the ultimate objectives of this clinical research?
"Over a period of 6 months, the primary objective this clinical trial is to assess pain levels. Secondary goals include assessing mortality rates both in-hospital and 30 days post hospitalisation, duration spent in ICU/Acute Care Hospital Units, and instances of respiratory complications such as pneumothorax or unplanned intubation."
Share this study with friends
Copy Link
Messenger